Genotype-guided approach to improve cardiometabolic health using natriuretic peptides
Official title: Atrial Natriuretic Peptide and Regulation of Cardiometabolic Health: A Genotype-Guided Human Physiological Study
Run by University of Alabama at Birmingham · NCT05216042 · Data updated 2026-11-12
This study is testing if a special approach using natriuretic peptides can help improve heart and metabolic health in adults with a certain genetic variant that leads to lower levels of these peptides.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | University of Alabama at Birmingham Academic / other |
| Locations | 1 site (Birmingham, Alabama) |
| Status | Recruiting |
| Started | April 1, 2022 |
| Main results expected | April 1, 2027 |
| Study ends | April 30, 2027 |
| Registry record updated | October 5, 2026 |
| Trial ID | NCT05216042 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older who consent to genetic material collection and are willing to adhere to the study protocol.
✕Probably not a fit
Patients with a history of cardiovascular diseases, diabetes, or those with severe obesity (BMI > 45 kg/m2) may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the role of natriuretic peptides (NPs) in regulating cardiometabolic health, particularly in individuals with genetically lower NP levels. It focuses on understanding how exercise and glucose challenges affect NP responses in adults who carry a specific genetic variant associated with lower NP levels. The study aims to explore the metabolic benefits of NPs and their potential to mitigate risks associated with cardiovascular diseases and diabetes. Participants will undergo dietary assessments, exercise capacity evaluations, and challenges to assess their metabolic responses.
Why it matters
Potential benefit: If successful, this study could lead to improved strategies for managing cardiometabolic health in individuals with low natriuretic peptide levels.
How similar studies have gone: Previous studies have indicated the importance of natriuretic peptides in metabolic health, suggesting that this approach may yield beneficial insights, although the specific genetic focus is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults: Age more than or equal to 18; an equal number of Males and Females * Consent to the collection of genetic material * Willing to adhere to the study protocol Exclusion Criteria: * Age \<18, at screening. * BMI \>45 kg/m2. * Blood pressure more than 140/90 mmHg. * Participants who are taking more than 2 hypertension medications. * History of diabetes or fasting plasma glucose \>126 mg/dl or HbA1C\>=6.5% or prior treatment with antidiabetic medication. * Have any past or present history of cardiovascular diseases (stroke, seizure, myocardial infarction, heart failure, transient ischemic attack, angina, or cardiac arrhythmia) * Women who are pregnant or breastfeeding or who can become pregnant and not practicing an acceptable method of birth control during the study (including abstinence); * Estimated GFR \< 60 ml/min/1.73 m2; albumin creatinine ratio ≥30 mg/g * Hepatic Transaminase (AST and ALT) levels \>3x the upper limit of normal * Anemia (men, Hct \< 38%; women, Hct \<36%) * Inability to exercise on a treadmill
Where it's running
-
University of Alabama at Birmingham
Birmingham, Alabama, United States Recruiting
Study contacts
- Principal investigator: Pankaj Arora, MD, FAHA — University of Alabama at Birmingham
- Study coordinator: Nehal Vekariya, MS
- Email: nvekariya@uabmc.edu
- Phone: 205-934-7173
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
A biobank for cardiovascular research at UAB
This study is collecting blood and DNA samples from people to see how genetics relate to heart disease, diabetes, and obesity, with the goal of finding better ways to prevent and treat these conditions.
-
Targeting blood pressure rhythms in obese individuals
This study is testing if giving blood pressure medications at certain times can help people with obesity and high blood pressure feel better and manage their condition more effectively.
-
Improving metabolic health in Black individuals using natriuretic peptide augmentation
This study is testing if a medication can boost certain hormones to improve metabolic health in Black individuals at risk for diabetes.
-
Postpartum program to prevent cardiometabolic problems after preeclampsia
This study will test a 9-month app-based support program to lower blood pressure and help with weight loss in first-time mothers who recently had preeclampsia.
-
Pre-screening to identify adults who may be eligible for future metabolic and mental health opportunities.
This prescreening will see if adults with metabolic conditions or mental health disorders qualify for upcoming clinical opportunities by collecting health history, basic tests, and a doctor interview.
-
Inspire HER: a heart-health and stress-support program for Black women
This project will test whether the Inspire HER lifestyle program helps Black women with higher heart disease risk improve heart health and manage stress.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.